145 related articles for article (PubMed ID: 18621634)
21. Antibody microarrays as tools for biomarker discovery.
Sanchez-Carbayo M
Methods Mol Biol; 2011; 785():159-82. PubMed ID: 21901599
[TBL] [Abstract][Full Text] [Related]
22. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
23. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
[TBL] [Abstract][Full Text] [Related]
24. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
[TBL] [Abstract][Full Text] [Related]
25. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
Murphy KM; Chen F; Clark DP
Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
[TBL] [Abstract][Full Text] [Related]
26. Primer: genomic and proteomic tools for the molecular dissection of disease.
Walker EJ; Siminovitch KA
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
[TBL] [Abstract][Full Text] [Related]
27. Strategies for plasma proteomic profiling of cancers.
Omenn GS
Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
[TBL] [Abstract][Full Text] [Related]
28. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
30. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
31. [Proteomics for biomarker development toward personalized medicine].
Kondo T
Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
[TBL] [Abstract][Full Text] [Related]
32. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
33. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer.
Zhang D; Salto-Tellez M; Putti TC; Do E; Koay ES
Mod Pathol; 2003 Jan; 16(1):79-84. PubMed ID: 12527717
[TBL] [Abstract][Full Text] [Related]
34. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA
Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417
[TBL] [Abstract][Full Text] [Related]
35. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Kulasingam V; Diamandis EP
Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
[TBL] [Abstract][Full Text] [Related]
36. Tissue microarray studies in bladder cancer.
Hartmann A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
[TBL] [Abstract][Full Text] [Related]
37. [Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].
Jacquemier J; Ginestier C; Charafe-Jauffret E; Bertucci F; Bege T; Geneix J; Birnbaum D
Ann Pathol; 2003 Dec; 23(6):623-32. PubMed ID: 15094604
[TBL] [Abstract][Full Text] [Related]
38. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
39. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins.
Imai S; Nagano K; Yoshida Y; Okamura T; Yamashita T; Abe Y; Yoshikawa T; Yoshioka Y; Kamada H; Mukai Y; Nakagawa S; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Jan; 32(1):162-9. PubMed ID: 20933274
[TBL] [Abstract][Full Text] [Related]
40. OMICS and brain tumour biomarkers.
Petrik V; Loosemore A; Howe FA; Bell BA; Papadopoulos MC
Br J Neurosurg; 2006 Oct; 20(5):275-80. PubMed ID: 17129872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
